PRDX4-enriched exosomes from adipose stem cells enhance diabetic wound repair through angiogenic activation.
Chen X., Jiang Y., Tao Y., Zhang W., Zhuo H., Sun Y.
Animal Study on Diabetic Foot, Chronic Wound, published in Burns (2026) — summary generated from the PubMed abstract.
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Animal Study
- Journal
- Burns (2026)
- Country
- Netherlands
- Reported sample size
- —
- Source database
- PubMed
- PMID
- 42296599
- DOI
- 10.1016/j.burns.2026.108061
Abstract (original English)
Background Diabetic (DM) wounds are a major challenge in dermatology. Despite the therapeutic effectiveness of stem cell therapy in wound repair, clinical applications remain limited. We investigated whether adipose-derived exosomes (Exos) can promote healing in diabetic mice. Methods High-throughput sequencing (HTS) was employed to study abnormal circular RNA expression in ulcerated tissue with or without adipose-derived stem cell (ADSC)-Exo treatment. EPCs were employed to analyze reactive oxygen species (ROS), apoptosis, and angiogenic differentiation functions. A DM ulceration mouse model was generated and Exo therapeutic effects were investigated. Results Data demonstrated that ADSC-Exo treatment enhances wound healing (WH) of diabetic mice through inhibiting ROS deposition and restoring angiogenic function under high glucose (HG) conditions. The HTS in the current research revealed that ADSC-Exo treatment resulted in altered gene expression, including of peroxiredoxin 4 (PRDX4). PRDX4 downregulation inhibited the Exo protective effects on WH. PRDX4 overexpression inhibited HG-induced EPC dysfunction and augmented Exo therapeutic effects on WH. Conclusion Our data indicated that Exos derived from ADSCs promoted diabetic wound (DW) healing through delivering PRDX4 and improving endothelial cell function, which aids in the development of stem cell-based therapeutic treatment
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
- • This is preclinical work; animal or laboratory results cannot be applied to humans.
Evidence level
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.
Related research
- Level AMeta-analysisPubMed
Efficacy of Stem Cell-Derived Exosomes in Promoting Diabetic Foot Ulcer Healing: A Meta-Analysis of Preclinical Animal Studies.
Meta-analysis on Diabetic Foot, Chronic Wound, published in J Diabetes Res (2026) — summary generated from the PubMed abstract.
- 2026
J Diabetes Res - Level AMeta-analysisEurope PMC
Bone marrow-derived mesenchymal stem cells combined with intramuscular injection promote the healing of diabetic foot ulcers: a systematic review and meta-analysis
Meta-analysis with a reported sample of 2059 on Diabetic Foot, Chronic Wound, published in Front Endocrinol (Lausanne) (2026) — summary generated from the PubMed abstract.
- 2026
- n = 2059
Front Endocrinol (Lausanne) - Level AMeta-analysisEurope PMC
Comparative efficacy of advanced therapeutic modalities for diabetic foot ulcers: a systematic review and meta-analysis including NPWT, stem cells, ESWT, and bioengineered treatments
Meta-analysis on Diabetic Foot, published in Front Bioeng Biotechnol (2026) — summary generated from the PubMed abstract.
- 2026
Front Bioeng Biotechnol - Level AMeta-analysisPubMed
Therapeutic potential of adipose-derived stem cells for diabetic foot ulcers: a systematic review and meta-analysis.
Meta-analysis on Diabetic Foot, Chronic Wound, published in Diabetol Metab Syndr (2025) — summary generated from the PubMed abstract.
- 2025
Diabetol Metab Syndr6 citations - Level AMeta-analysisPubMed
A meta-analysis on application and prospect of cell therapy in the treatment of diabetes mellitus.
Meta-analysis on Diabetic Foot, Autoimmune Research, published in Stem Cell Res Ther (2025) — summary generated from the PubMed abstract.
- 2025
Stem Cell Res Ther - Level AMeta-analysisEurope PMC
Comparison of the efficacy of 12 interventions in the treatment of diabetic foot ulcers: a network meta-analysis
Meta-analysis with a reported sample of 356 on Diabetic Foot, Chronic Wound, published in PeerJ (2025) — summary generated from the PubMed abstract.
- 2025
- n = 356
PeerJ1 citations